News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

The Day In Review: Pfizer Inc. (PFE) Buys Embrex (EMBX) For $155 Million



11/15/2006 7:09:49 PM

November 15, 2006 – Pfizer bought an ag-biotech company called Embrex for $17 per share or a total of $155 million; Pfizer also announced that high doses of Lipitor reduced the incidence of major cardiovascular events by 32%; StemCells made the first transplantation of its human neural stem cell product in a Phase I trial; Emergent BioSolutions priced its IPO at $12.50 per share but dropped in open market trading; Trimeris will focus on making its HIV drug Fuzeon profitable; and Immunomedics said the clinical hold on its lupus drug has been lifted. The Centient Biotech 200™ rose 16 points to 3971, an increase of .40%. More details...

Read at ChinaBio Today


comments powered by Disqus
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES